Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,398 | -4,116 | -13,399 | -9,244 | -5,520 |
| Depreciation Amortization | 520 | 262 | 941 | 683 | 462 |
| Other Working Capital | 1,978 | -226 | 1,238 | 430 | -594 |
| Other Operating Activity | 384 | 204 | 940 | 475 | 247 |
| Operating Cash Flow | $-6,516 | $-3,876 | $-10,280 | $-7,656 | $-5,405 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -348 | -210 | -82 | -84 | -80 |
| Purchase Sale Intangibles | -117 | -117 | N/A | 0 | N/A |
| Other Investing Activity | -367 | -367 | 0 | 0 | 0 |
| Investing Cash Flow | $-715 | $-577 | $-82 | $-84 | $-80 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -804 | -402 | -276 | -8 | -8 |
| Common Stock Issued | 7,725 | 7,694 | 20,692 | 20,682 | 14,308 |
| Financing Cash Flow | $6,921 | $7,292 | $20,416 | $20,674 | $14,300 |
| Beginning Cash Position | 18,400 | 18,400 | 8,346 | 8,346 | 8,346 |
| End Cash Position | 18,090 | 21,239 | 18,400 | 21,280 | 17,161 |
| Net Cash Flow | $-310 | $2,839 | $10,054 | $12,934 | $8,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,516 | -3,876 | -10,280 | -7,656 | -5,405 |
| Capital Expenditure | -348 | -210 | -144 | -134 | -80 |
| Free Cash Flow | -6,864 | -4,086 | -10,424 | -7,790 | -5,485 |